Streetbeat News

Price Targets

XPOF

Bank of America Securities has downgraded Xponential Fitness from 'Buy' to 'Neutral' and reduced its price target from $35 to $16. This has led to a decrease in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:13 pm

APLS

Needham analyst Joseph Stringer maintains a 'Buy' rating on Apellis Pharmaceuticals (NASDAQ:APLS) and raises the price target from $60 to $63.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:11 pm

AMGN

RBC Capital analyst Gregory Renza has maintained a 'Sector Perform' rating on Amgen (NASDAQ:AMGN) and raised the price target from $253 to $256.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:10 pm

W

Needham analyst Anna Andreeva has maintained a 'Buy' rating on Wayfair (NYSE:W) but lowered the price target from $100 to $75.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:06 pm

ADUS

RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on Addus HomeCare (NASDAQ:ADUS), but lowered the price target from $109 to $102.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:01 pm

ARDX

HC Wainwright & Co. analyst Ed Arce maintains a 'Buy' rating on Ardelyx (NASDAQ:ARDX) and raises the price target from $9 to $11.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:58 pm

AME

RBC Capital analyst Deane Dray has maintained an 'Outperform' rating on AMETEK (AME) and raised the price target from $183 to $186.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:57 pm

TSX:TIH

RBC Capital analyst Sabahat Khan maintains an Outperform rating on Toromont Industries (TSX:TIH) but lowers the price target from C$131 to C$125.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:52 pm

URG

Roth MKM analyst Joe Reagor maintains a Buy rating on Ur-Energy (AMEX:URG) but lowers the price target from $2.4 to $2.2.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:50 pm

BIOX

Roth MKM analyst Brian Wright maintains a Buy rating on Bioceres Crop Solutions (NASDAQ:BIOX) but lowers the price target from $31 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:47 pm